Terms: = Bone cancer AND SYK, P43405, 6850, ENSG00000165025 AND Treatment
15 results:
1. Self-supervised tumor segmentation and prognosis prediction in osteosarcoma using multiparametric MRI and clinical characteristics.
Zhou Z; Xie P; Dai Z; Wu J
Comput Methods Programs Biomed; 2024 Feb; 244():107974. PubMed ID: 38154327
[TBL] [Abstract] [Full Text] [Related]
2. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
3. miR-96-5p is the tumor suppressor in osteosarcoma via targeting syk.
Wang T; Xu Y; Liu X; Zeng Y; Liu L
Biochem Biophys Res Commun; 2021 Oct; 572():49-56. PubMed ID: 34343834
[TBL] [Abstract] [Full Text] [Related]
4. All-Trans Retinoic Acid Impairs Platelet Function and Thrombus Formation and Inhibits Protein Kinase CßI/δ Phosphorylation.
Luo Q; Wei G; Wang X; Xu X; Ju W; Li Z; Gardiner EE; Andrews RK; Zeng L; Xu K; Qiao J
Thromb Haemost; 2019 Oct; 119(10):1655-1664. PubMed ID: 31370073
[TBL] [Abstract] [Full Text] [Related]
5. Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.
Lossos C; Liu Y; Kolb KE; Christie AL; Van Scoyk A; Prakadan SM; Shigemori K; Stevenson KE; Morrow S; Plana OD; Fraser C; Jones KL; Liu H; Pallasch CP; Modiste R; Nguyen QD; Craig JW; Morgan EA; Vega F; Aster JC; Sarosiek KA; Shalek AK; Hemann MT; Weinstock DM
Cancer Discov; 2019 Jul; 9(7):944-961. PubMed ID: 31040105
[TBL] [Abstract] [Full Text] [Related]
6. bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Wang D; Liu P; Zhang Y; Liu HY; Shen D; Che YQ
Biomed Res Int; 2018; 2018():1042597. PubMed ID: 30534553
[TBL] [Abstract] [Full Text] [Related]
7. Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors.
Luo Q; Wei G; Wu X; Tang K; Xu M; Wu Y; Liu Y; Li X; Sun Z; Ju W; Qi K; Chen C; Yan Z; Cheng H; Zhu F; Li Z; Zeng L; Xu K; Qiao J
J Transl Med; 2018 Nov; 16(1):311. PubMed ID: 30442147
[TBL] [Abstract] [Full Text] [Related]
8. Increased syk activity is associated with unfavorable outcome among patients with acute myeloid leukemia.
Boros K; Puissant A; Back M; Alexe G; Bassil CF; Sinha P; Tholouli E; Stegmaier K; Byers RJ; Rodig SJ
Oncotarget; 2015 Sep; 6(28):25575-87. PubMed ID: 26315286
[TBL] [Abstract] [Full Text] [Related]
9. Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.
Bernard S; Danglade D; Gardano L; Laguillier C; Lazarian G; Roger C; Thieblemont C; Marzec J; Gribben J; Cymbalista F; Varin-Blank N; Ledoux D; Baran-Marszak F
Int J Cancer; 2015 Jun; 136(12):2761-74. PubMed ID: 25388373
[TBL] [Abstract] [Full Text] [Related]
10. syk is a candidate kinase target for the treatment of advanced prostate cancer.
Ghotra VP; He S; van der Horst G; Nijhoff S; de Bont H; Lekkerkerker A; Janssen R; Jenster G; van Leenders GJ; Hoogland AM; Verhoef EI; Baranski Z; Xiong J; van de Water B; van der Pluijm G; Snaar-Jagalska BE; Danen EH
Cancer Res; 2015 Jan; 75(1):230-40. PubMed ID: 25388286
[TBL] [Abstract] [Full Text] [Related]
11. A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (syk) inhibitor.
Burke RT; Meadows S; Loriaux MM; Currie KS; Mitchell SA; Maciejewski P; Clarke AS; Dipaolo JA; Druker BJ; Lannutti BJ; Spurgeon SE
Oncotarget; 2014 Feb; 5(4):908-15. PubMed ID: 24659719
[TBL] [Abstract] [Full Text] [Related]
12. Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.
Srivastava S; Pelloso D; Feng H; Voiles L; Lewis D; Haskova Z; Whitacre M; Trulli S; Chen YJ; Toso J; Jonak ZL; Chang HC; Robertson MJ
Cancer Immunol Immunother; 2013 Jun; 62(6):1073-82. PubMed ID: 23604103
[TBL] [Abstract] [Full Text] [Related]
13. Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages.
Greuber EK; Pendergast AM
J Immunol; 2012 Dec; 189(11):5382-92. PubMed ID: 23100514
[TBL] [Abstract] [Full Text] [Related]
14. The ITK-syk fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
[TBL] [Abstract] [Full Text] [Related]
15. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
[TBL] [Abstract] [Full Text] [Related]
